Is Karyopharm Therapeutics Inc. (KPTI) Going To Reach Wallstreet’s Targets?

Karyopharm Therapeutics Inc. (KPTI) has seen some recent movement in the market and its shares closed at $15.76 yesterday. People are starting to take notice of KPTI as the shares traded as high as $16.50 and as low as $15.48 in the previous market day.

Karyopharm Therapeutics Inc. (KPTI) average trading volume is 1.92M. However, in the previous market day Karyopharm Therapeutics Inc. (KPTI) traded 3,553,880 shares. The First support level on KPTI is $14.04 and the First upside resistance level on KPTI is $27.72. KPTI 50day moving average is $18.50 and KPTI 200-day moving average is $19.00.

Karyopharm Therapeutics Inc. (KPTI) recent performance has been indicated by the recent movement in KPTI shares. KPTI has performed -19.47% over the past month, KPTI has performed -19.71% over the past quarter and KPTI has shown 100.76% over the past 12 months. Karyopharm Therapeutics Inc. (KPTI) has a 1 year range of $8.02 to $29.61. Karyopharm Therapeutics Inc. (KPTI) is trading 108.74% from its 1 year low and -46.77% from its 1 year high. Karyopharm Therapeutics Inc. (KPTI) is indicating a 25.27% short float indicating the amount short in the float.

KPTI has 67.63M shares outstanding and 66.07M shares in the float. Karyopharm Therapeutics Inc. (KPTI) currently has a market cap of $1.19B and income of -186.40M. The EPS next quarter for KPTI is -0.58 and forecasted EPS next year is 43.30%. The market cap of Karyopharm Therapeutics Inc. (KPTI) at $1.19B represents how many People own shares of KPTI and is calculated off the last price ($15.76) of KPTI and the amount of shares outstanding (67.63M) with Karyopharm Therapeutics Inc. (KPTI).

Karyopharm Therapeutics Inc. (KPTI) has total cash (mrq) of 352.13M, total cash per share (mrq) of 4.82, total debt of KPTI rests at 126.23M and total debt/equity (mrq) is 75.97. . Karyopharm Therapeutics Inc. (KPTI) operating cash flow (ttm) is -169.21M, KPTI leveraged free cash flow (ttm) is -100.83M.

KPTI is trading -13.96% below (bearish) its SMA20, -14.47% below (bearish) its SMA50 and -12.73% below (bearish) its SMA200.

Related Articles

Zebra (NASDAQ: ZBRA) And XMReality Inks Partnership Agreement

Zebra Technologies Corporation (NASDAQ: ZBRA) and XMReality publicized that the two have signed an agreement to work together and collaborate on ideas that offer...

Elanco (NYSE: ELAN) Launch Public Offering Of Common Stock

Elanco Animal Health Inc. (NYSE: ELAN) shares that it is planning to commence the public offering of 54,500,000 shares of common stock. It will...

Jacobs (NYSE: J) Partners with PA Consulting

Jacobs Engineering Group, Inc. (NYSE: J), a famous construction company announced that it will be collaborating with PA Consulting. The firm has purchased an...

Get in Touch

19,000FansLike
35,222FollowersFollow
22,458FollowersFollow

Latest Posts

Zebra (NASDAQ: ZBRA) And XMReality Inks Partnership Agreement

Zebra Technologies Corporation (NASDAQ: ZBRA) and XMReality publicized that the two have signed an agreement to work together and collaborate on ideas that offer...

Elanco (NYSE: ELAN) Launch Public Offering Of Common Stock

Elanco Animal Health Inc. (NYSE: ELAN) shares that it is planning to commence the public offering of 54,500,000 shares of common stock. It will...

Jacobs (NYSE: J) Partners with PA Consulting

Jacobs Engineering Group, Inc. (NYSE: J), a famous construction company announced that it will be collaborating with PA Consulting. The firm has purchased an...

Fuwei (NASDAQ: FFHL) Plans To Sell Dornier Production Line

Fuwei Films (Holdings) Co., Ltd. (NASDAQ: FFHL) recently declared that it will be closing its Dornier line of production as early as possible. Fuwei...

PPG Industries (NYSE: PPG) Announces Accquisition Of Ennis-Flint

PPG Industries, Inc. (NYSE: PPG) is planning to buy Ennis-Flint in a deal valued at nearly $1.15 billion. The decision to acquire Ennis-Flint will...